US Edition
Rovin Capital UT ADV Reduces Holdings in Bristol Myers Squibb Company (NYSE:BMY)
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Rovin Capital UT ADV Reduces Holdings in Bristol Myers Squibb Company (NYSE:BMY)
Rovin Capital UT ADV cut its holdings in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 23.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,944 shares of the biopharmaceutical company’s stock after selling 3,372 shares during the quarter. Rovin […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
